Table of Contents

Global HIV Point-of-care Testing Market Growth 2019-2024

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global HIV Point-of-care Testing Consumption 2014-2024
  • 2.1.2 HIV Point-of-care Testing Consumption CAGR by Region
• 2.2 HIV Point-of-care Testing Segment by Type
  • 2.2.1 Testing Equipment
  • 2.2.2 Testing Reagent
• 2.3 HIV Point-of-care Testing Consumption by Type
  • 2.3.1 Global HIV Point-of-care Testing Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global HIV Point-of-care Testing Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global HIV Point-of-care Testing Sale Price by Type (2014-2019)
• 2.4 HIV Point-of-care Testing Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Home Care Setting
• 2.5 HIV Point-of-care Testing Consumption by Application
  • 2.5.1 Global HIV Point-of-care Testing Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global HIV Point-of-care Testing Value and Market Share by Application (2014-2019)
  • 2.5.3 Global HIV Point-of-care Testing Sale Price by Application (2014-2019)

3 Global HIV Point-of-care Testing by Manufacturers

• 3.1 Global HIV Point-of-care Testing Sales Market Share by Manufacturers
  • 3.1.1 Global HIV Point-of-care Testing Sales by Manufacturers (2017-2019)
  • 3.1.2 Global HIV Point-of-care Testing Sales Market Share by Manufacturers (2017-2019)
• 3.2 Global HIV Point-of-care Testing Revenue Market Share by Manufacturers
  • 3.2.1 Global HIV Point-of-care Testing Revenue by Manufacturers (2017-2019)
  • 3.2.2 Global HIV Point-of-care Testing Revenue Market Share by Manufacturers (2017-2019)
• 3.3 Global HIV Point-of-care Testing Sale Price by Manufacturers
• 3.4 Global HIV Point-of-care Testing Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  • 3.4.1 Global HIV Point-of-care Testing Manufacturing Base Distribution and Sales Area by Manufacturers
  • 3.4.2 Players HIV Point-of-care Testing Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 HIV Point-of-care Testing by Regions

• 4.1 HIV Point-of-care Testing by Regions
  • 4.1.1 Global HIV Point-of-care Testing Consumption by Regions
  • 4.1.2 Global HIV Point-of-care Testing Value by Regions
• 4.2 Americas HIV Point-of-care Testing Consumption Growth
• 4.3 APAC HIV Point-of-care Testing Consumption Growth
• 4.4 Europe HIV Point-of-care Testing Consumption Growth
• 4.5 Middle East & Africa HIV Point-of-care Testing Consumption Growth

5 Americas

• 5.1 Americas HIV Point-of-care Testing Consumption by Countries
  • 5.1.1 Americas HIV Point-of-care Testing Consumption by Countries (2014-2019)
  • 5.1.2 Americas HIV Point-of-care Testing Value by Countries (2014-2019)
• 5.2 Americas HIV Point-of-care Testing Consumption by Type
• 5.3 Americas HIV Point-of-care Testing Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC HIV Point-of-care Testing Consumption by Countries
  • 6.1.1 APAC HIV Point-of-care Testing Consumption by Countries (2014-2019)
  • 6.1.2 APAC HIV Point-of-care Testing Value by Countries (2014-2019)
• 6.2 APAC HIV Point-of-care Testing Consumption by Type
• 6.3 APAC HIV Point-of-care Testing Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe HIV Point-of-care Testing by Countries
  • 7.1.1 Europe HIV Point-of-care Testing Consumption by Countries (2014-2019)
  • 7.1.2 Europe HIV Point-of-care Testing Value by Countries (2014-2019)
• 7.2 Europe HIV Point-of-care Testing Consumption by Type
• 7.3 Europe HIV Point-of-care Testing Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa HIV Point-of-care Testing by Countries
  • 8.1.1 Middle East & Africa HIV Point-of-care Testing Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa HIV Point-of-care Testing Value by Countries (2014-2019)
• 8.2 Middle East & Africa HIV Point-of-care Testing Consumption by Type
• 8.3 Middle East & Africa HIV Point-of-care Testing Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 HIV Point-of-care Testing Distributors
• 10.3 HIV Point-of-care Testing Customer

11 Global HIV Point-of-care Testing Market Forecast

• 11.1 Global HIV Point-of-care Testing Consumption Forecast (2019-2024)
• 11.2 Global HIV Point-of-care Testing Forecast by Regions
  • 11.2.1 Global HIV Point-of-care Testing Forecast by Regions (2019-2024)
  • 11.2.2 Global HIV Point-of-care Testing Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global HIV Point-of-care Testing Forecast by Type
• 11.8 Global HIV Point-of-care Testing Forecast by Application

12 Key Players Analysis

• 12.1 Adaltis
  • 12.1.1 Company Details
  • 12.1.2 HIV Point-of-care Testing Product Offered
  • 12.1.3 Adaltis HIV Point-of-care Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Adaltis News
• 12.2 BD
  • 12.2.1 Company Details
  • 12.2.2 HIV Point-of-care Testing Product Offered
  • 12.2.3 BD HIV Point-of-care Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 BD News
• 12.3 Abbott
  • 12.3.1 Company Details
  • 12.3.2 HIV Point-of-care Testing Product Offered
  • 12.3.3 Abbott HIV Point-of-care Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Abbott News
• 12.4 Roche
  • 12.4.1 Company Details
  • 12.4.2 HIV Point-of-care Testing Product Offered
  • 12.4.3 Roche HIV Point-of-care Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Roche News
• 12.5 Biomerieux
  • 12.5.1 Company Details
  • 12.5.2 HIV Point-of-care Testing Product Offered
  • 12.5.3 Biomerieux HIV Point-of-care Testing Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Biomerieux News

...

13 Research Findings and Conclusion

According to this study, over the next five years the HIV Point-of-care Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in HIV Point-of-care Testing business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of HIV Point-of-care Testing market by product type, application, key manufacturers and key regions and countries.

This study considers the HIV Point-of-care Testing value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Testing Equipment
Testing Reagent

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Home Care Setting

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Adaltis
BD
Abbott
Roche
Biomerieux
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global HIV Point-of-care Testing consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of HIV Point-of-care Testing market by identifying its various subsegments.
Focuses on the key global HIV Point-of-care Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the HIV Point-of-care Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of HIV Point-of-care Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.